These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 17643590
1. Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Aquilina M, Baldazzi F, Silenzi S, Taglieri N, Grosseto D, Bacchi-Reggiani ML, Guastaroba P, Grilli R, Branzi A. Am Heart J; 2007 Aug; 154(2):366-72. PubMed ID: 17643590 [Abstract] [Full Text] [Related]
2. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results. Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ. Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054 [Abstract] [Full Text] [Related]
3. ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours. Cubeddu RJ, Cruz-Gonzalez I, Kiernan TJ, Truong QA, Rosenfield K, Leinbach RC, Cadigan ME, Pomerantsev EV, Palacios IF. J Invasive Cardiol; 2009 Oct; 21(10):518-23. PubMed ID: 19805838 [Abstract] [Full Text] [Related]
4. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients. Kunadian B, Vijayalakshmi K, Dunning J, Thornley AR, Sutton AG, Muir DF, Wright RA, Hall JA, de Belder MA. J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036 [Abstract] [Full Text] [Related]
5. A regional system for delivery of primary percutaneous coronary intervention in ST-elevation myocardial infarction: STEMI-St. Cloud. Aplin R, Tiede D, Lovitz C, Gartner M, Robinson D, Xu H, Martin P, Erickson B, Schmidt W, Pelzel J, Wendt D, Mahowald J. J Invasive Cardiol; 2009 Dec; 21(12):639-44. PubMed ID: 19966367 [Abstract] [Full Text] [Related]
6. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF. Chin Med J (Engl); 2008 Mar 20; 121(6):485-91. PubMed ID: 18364130 [Abstract] [Full Text] [Related]
7. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Kozieradzka A, Kamiński KA, Pepiński W, Janica J, Korecki J, Skolimowski K, Frankowska E, Kralisz P, Bonda TA, Dobrzycki S, Musiał WJ. Kardiol Pol; 2006 Dec 20; 64(12):1350-5; discussion 1356. PubMed ID: 17206538 [Abstract] [Full Text] [Related]
8. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T, FAST-MI Investigators. Circulation; 2008 Jul 15; 118(3):268-76. PubMed ID: 18591434 [Abstract] [Full Text] [Related]
9. Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. McKay RG, Dada MR, Mather JF, Mennet RR, Murphy DJ, Maloney KW, Hirst JA, Kiernan FJ. Am J Cardiol; 2009 Feb 01; 103(3):316-21. PubMed ID: 19166682 [Abstract] [Full Text] [Related]
10. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF. Coron Artery Dis; 2008 Jun 01; 19(4):271-7. PubMed ID: 18480672 [Abstract] [Full Text] [Related]
13. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative). Alexander D, Mann N, Ou FS, Peterson ED, Ohman EM, Gibler WB, Roe MT. Am J Cardiol; 2008 Nov 15; 102(10):1335-40. PubMed ID: 18993151 [Abstract] [Full Text] [Related]
14. Comparison of official hours versus non-official hours: percutaneous coronary intervention in acute ST-elevation myocardial infarction patients. Srimahachota S, Boonyaratavej S, Udayachalerm W, Buddhari W, Chaipromprasit J, Suithichaiyakul T. J Med Assoc Thai; 2007 Jan 15; 90(1):45-51. PubMed ID: 17621732 [Abstract] [Full Text] [Related]
16. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H, Sienkiewicz J, Musial WJ. Eur Heart J; 2007 Oct 15; 28(20):2438-48. PubMed ID: 17884846 [Abstract] [Full Text] [Related]